Juvenescence

Juvenescence is the famous Corporate Investor, which was founded in 2016. The company was established in Europe in Isle of Man. The main department of described Corporate Investor is located in the Douglas.

This organization was formed by Declan Doogan, Greg Bailey, Jim Mellon.

The top amount of exits for fund were in 2018. Comparing to the other companies, this Juvenescence performs on 19 percentage points less the average number of lead investments. The common things for fund are deals in the range of 5 - 10 millions dollars. The high activity for fund was in 2018. Despite it in 2019 the fund had an activity. The fund is constantly included in 2-6 investment rounds annually. Speaking about the real fund results, this Corporate Investor is 10 percentage points more often commits exit comparing to other organizations.

The usual cause for the fund is to invest in rounds with 1-2 partakers. Despite the Juvenescence, startups are often financed by Jim Mellon, KIZOO, John Mauldin. The meaningful sponsors for the fund in investment in the same round are WuXi AppTec, Pavilion Capital, Longevity Vision Fund. In the next rounds fund is usually obtained by Longevity Vision Fund, Sinovation Ventures, Qiming Venture Partners.

Besides, a startup requires to be at the age of 1 and less years to receive the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. The fund has specific favorite in a number of founders of portfolio startups. Among the most successful fund investment fields, there are Genetics, Therapeutics. Among the most popular portfolio startups of the fund, we may highlight Insilico Medicine, AgeX Therapeutics, BHB Therapeutics.

Notable deals

Review

• No reviews are submitted yet.